Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP24A1 | Q07973 | 2/20 | 0.37 |
| ▸ | TBXAS1 | P24557 | 4/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2451086 | 0.81 | CYP24A1 (0.38) | CYP24A1TBXAS1AHRFAAHMGLL | |
| SCHEMBL22162639 | 0.80 | CYP24A1 (0.38) | CYP24A1TBXAS1AHRADRB2ADRB1 | |
| SCHEMBL1490570 | 0.79 | CYP24A1 (0.38) | CYP24A1TBXAS1AHR | |
| SCHEMBL31406607 | 0.78 | CYP24A1 (0.39) | CYP24A1TBXAS1AHRFAAHMGLL | |
| SCHEMBL10663537 | 0.78 | CYP24A1 (0.37) | CYP24A1TBXAS1AHRFAAHMGLL | |
| SCHEMBL26596806 | 0.77 | CYP24A1 (0.35) | CYP24A1TBXAS1ADRB2ADRB1ADRB3 | |
| SCHEMBL22162630 | 0.77 | CYP24A1 (0.33) | CYP24A1TBXAS1AHRADRB2ADRB1 | |
| SCHEMBL15884092 | 0.77 | CYP24A1 (0.36) | CYP24A1TBXAS1AHRFAAHMGLL | |
| SCHEMBL19152231 | 0.76 | CYP24A1 (0.35) | CYP24A1TBXAS1ADRB2ADRB1ADRB3 | |
| SCHEMBL9218682 | 0.75 | CYP24A1 (0.34) | CYP24A1TBXAS1AHRADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | THE GEORGE WASHINGTON UNIVERSITY (US) | 2025-01-14 | — | — | US | claimed |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY | 2020-06-04 | — | — | US | claimed |
| WO-2018213821-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY (US) | 2018-11-22 | — | — | WO | claimed |
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | THE GEORGE WASHINGTON UNIVERSITY (US) | 2025-01-14 | — | — | US | disclosed |
| US-11799133-B2 | Non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery including the same | LG ENERGY SOLUTION, LTD. | 2023-10-24 | — | — | US | disclosed |
| US-20210328266-A1 | Electrolyte Solution For Lithium Secondary Battery and Lithium Secondary Battery Including the Same | LG ENERGY SOLUTION, LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
| CN-113381071-A | Electrolyte and preparation method and application thereof | 惠州亿纬锂能股份有限公司 | 2021-09-10 | — | — | CN | disclosed |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY | 2020-06-04 | — | — | US | disclosed |
| WO-2018213821-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY (US) | 2018-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | MLX, LDHA, CA2 | CYP24A1 3320/4885TBXAS1 4677/4885AHR 582/4885 |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | MLX, LDHA, CA2 | CYP24A1 3320/4885TBXAS1 4677/4885AHR 582/4885 |
| US-11799133-B2 | Non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery including the same | CACNA1S, PDHB, CACNA1F | CYP24A1 1038/4885TBXAS1 4114/4885AHR 4284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.